Equity
€191,250 from €522,648 in 2013
Equity fell by 63% in 12 years.
DR. MOULOUD KALAAI
Lifetime
18 annual accounts with figures on one time axis, 22 filings since 2002peak €193,130 (2010)
€97,424▼ 18.3%
lowest -€49,489 (2025)
-€49,489▼ €114,843
peak €522,648 (2013)
€191,250▼ 20.6%
€44,661▲ 7.8%
Board1 name since 2021
1 directorMouloud Kalaai
Documentsfilings and deeds
06-10-202667 days late
2025micro format
Gross margin from €119,252 to €97,424Loss of €49,489Equity from €240,740 to €191,250Cash from €90,102 to €156,286
Key points
from the 2025 annual accountsResult
-€49,489 -€49,489
From profit to loss in 2025, after a profit of €65,353 in 2024.
Turnover
≈ €220,000 estimated
The micro format states no turnover.
Liquidity
3.78 was 2.48 in 2024
Short-term debts rose from €40,227 to €44,661.
Filings
22 annual accounts 67 days
Latest accounts filed late: after the legal deadline.
Position in the sector
-€49,489
Lower net result than 95% of companies in human health. Sector median €60,070 · 20,736 companies.
Checked score
94
Excellent
Financially stronger than 48% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,180 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025
08-2025: 0.2%▲ +0.1 percentage points vs 07-2025highest value
09-2025: < 0.1%▼ -0.2 percentage points vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026lowest value
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Loss of €49,489 (financial year 2025)
Last filed accounts filed 67 days late; 1 of the last 3 accounts late
lowers risk
Liquidity: current ratio 3.78, cash €156,286
Sector: Human health activities (NACE 86)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 81% on liquidity, 8% on profitability and 21% on growth.
The bankruptcy probability was computed on 06-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 5,831 companies had the same profile as DR. MOULOUD KALAAI has now. Each dot stands for 15 companies, two years later.
84.6%
were still trading
13.4%
stopped another way
1.7%
went bankrupt
Another 0.3% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of DR. MOULOUD KALAAI itself is lower: < 0.1% within 12 months. It rests on far more data about DR. MOULOUD KALAAI than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 5,831 companies, not a prediction for DR. MOULOUD KALAAI. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €17,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.78 (2.48 in 2024), above the usual 1.5. Short-term debt is 18.9% and cash 66.2% of total assets. 18.9% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 67 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-10-2026, 67 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
67 days late
2024
26 days late
2023
26 days late
2022
22 days late
2021
31 days late
2020
61 days late
2019
88 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 46 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 August (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
07-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0473756116
Reappointment: Mouloud Kalaai (director)
General meeting of 19-01-2021 · Gazette deed
Incorporation
published on 19-01-2001 · Gazette deed
First establishment
Marebeekstraat 6, Bilzen-Hoeselt
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DR. MOULOUD KALAAI Bilzen-Hoeselt | €235,911 | €97,424 | 81.1% | - |
| DOKTER PATRICK VANDEPUT Kortenaken | €250,749 | €104,096 | 77.8% | - |
| VANGUERS BERNARD Florenville | €215,102 | €100,810 | 73.0% | - |
| Dr. VAN ROEY TOM, huisarts Sint-Niklaas | €258,892 | €92,953 | 82.2% | - |
| DOCTEUR MOIJSES NATACHA Braine-le-Comte | €266,265 | €100,904 | 46.0% | - |
| DAMOUN Auderghem | €211,197 | €101,927 | 47.3% | - |
| DR. WIM DE BACKER Schelle | €270,646 | €90,445 | 98.3% | - |
These companies have the same main activity as DR. MOULOUD KALAAI: general medical practice (NACE 86210). They are comparable in size and age: total assets between €211,000 and €271,000, founded between 1999 and 2003.
Official details
Source: KBO- Status
- Active since 09-01-2001Normal situation
- Activity
- General medical practiceNACE 86210
- Joint committee
- 330Health institutions and services · annual accounts 2025
- Establishment unit
- 2.392.235.8733740 Bilzen-Hoeselt, since 09-01-2001
- Financial year end
- 31 December
- Peppol
- Reachable since 17-09-2025
Insights on DR. MOULOUD KALAAI
DR. MOULOUD KALAAI files the micro format. That format states no turnover. The gross margin rose from €74,596 in 2006 to €97,424 in 2025.
The balance sheet grew most from 2009 to 2010 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR. MOULOUD KALAAI
- What is the company number of DR. MOULOUD KALAAI?
- The company number of DR. MOULOUD KALAAI is 0473.756.116. The VAT number is the same number with BE in front: BE 0473.756.116.
- Where is DR. MOULOUD KALAAI based?
- The registered office is at Marebeekstraat 6, 3740 Bilzen-Hoeselt.Company details
- What does DR. MOULOUD KALAAI do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of DR. MOULOUD KALAAI?
- DR. MOULOUD KALAAI is a private limited company (pre-2019) (BVBA).
- When was DR. MOULOUD KALAAI founded?
- DR. MOULOUD KALAAI was founded on 09-01-2001.
- Is DR. MOULOUD KALAAI still active?
- Yes, DR. MOULOUD KALAAI is an active enterprise in the KBO register.
- How many employees does DR. MOULOUD KALAAI have?
- DR. MOULOUD KALAAI had an average of 1.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does DR. MOULOUD KALAAI fall under?
- In its 2025 annual accounts, DR. MOULOUD KALAAI states joint committee 330 (Health institutions and services).
- What is the turnover of DR. MOULOUD KALAAI?
- The turnover in financial year 2025 is ≈ €220,000. This figure is estimated from the gross margin of €97,424 and 32 comparable companies (NACE 862). It probably lies between €170,000 and €280,000.
- Is DR. MOULOUD KALAAI profitable?
- In financial year 2025, DR. MOULOUD KALAAI made a loss of €49,489.
- Where can I find the annual accounts of DR. MOULOUD KALAAI?
- DR. MOULOUD KALAAI filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR. MOULOUD KALAAI due?
- DR. MOULOUD KALAAI must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.